BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6604546)

  • 1. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX.
    Bajaj SP; Rapaport SI; Russell WA
    Biochemistry; 1983 Aug; 22(17):4047-53. PubMed ID: 6604546
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation of human factor IX.
    Osterud B; Laake K; Prydz H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):553-63. PubMed ID: 239460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
    Osterud B; Rapaport SI
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5260-4. PubMed ID: 271951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
    Walsh PN; Bradford H; Sinha D; Piperno JR; Tuszynski GP
    J Clin Invest; 1984 May; 73(5):1392-9. PubMed ID: 6609171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).
    Fujikawa K; Legaz ME; Kato H; Davie EW
    Biochemistry; 1974 Oct; 13(22):4508-16. PubMed ID: 4473201
    [No Abstract]   [Full Text] [Related]  

  • 6. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
    Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa.
    Bajaj SP
    J Biol Chem; 1982 Apr; 257(8):4127-32. PubMed ID: 6978337
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules.
    Osterud B; Kasper CK; Prodanos C
    Thromb Res; 1979; 15(1-2):235-43. PubMed ID: 483278
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrinsic versus extrinsic coagulation. Kinetic considerations.
    Warn-Cramer BJ; Bajaj SP
    Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of Factor IX by tissue factor-Factor VII in a bovine plasma system lacking Factor X.
    Jesty J; Morrison SA
    Thromb Res; 1983 Oct; 32(2):171-81. PubMed ID: 6658712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipids accelerate factor IX activation by surface bound factor XIa.
    Mannhalter C; Schiffman S; Deutsch E
    Br J Haematol; 1984 Feb; 56(2):261-71. PubMed ID: 6607067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.
    Lindquist PA; Fujikawa K; Davie EW
    J Biol Chem; 1978 Mar; 253(6):1902-9. PubMed ID: 632245
    [No Abstract]   [Full Text] [Related]  

  • 16. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation.
    Lawson JH; Mann KG
    J Biol Chem; 1991 Jun; 266(17):11317-27. PubMed ID: 2040636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
    Rao LV; Rapaport SI
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
    Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
    Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.
    Hertzberg MS; Facey SL; Hogg PJ
    Blood; 1999 Jul; 94(1):156-63. PubMed ID: 10381508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.